BirdoTech 3rd. R&D Center in Chongqing International Biological City

January 6,2020

At the beginning of the New Year, the Banan District of Chongqing held a centralized signing contract for investment projects in 2020. Birdo (Shanghai) Pharmatech Co., Ltd. successfully settled in Chongqing International Biological Park.

BirdoTech is a national high-tech enterprise registered in Zhangjiang International Pharmaceutical Park, Shanghai. The company adheres to the corporate values of “Integrity, Credibility, Breakthrough, Innovation” takes “Your R&D partner in building a healthier future for all” as the enterprise vision to provide comprehensive and integrated R&D and production services for the global pharmaceutical industry.

The pharmaceutical R&D service platform project invested in Banan District covers an area of about 7,500 square meters, with a total investment of 60 million yuan. It is mainly to set up a drug synthesis and process development platform, including three sectors of Contract Research Organization (CRO), Contract Development Manufacture Organization (CDMO&CMO) as well as selling of molecular building blocks for drug research and development. After reaching the output, the annual sales revenue will be 150 million yuan.

Speech by Enterprise Representative

Representatives of contracted enterprises: Mr. Wang Lei, chairman of Birdo (Shanghai) Pharmatech Co., Ltd., Mr. Li Zhi, head of the upstream regional headquarters of Yangtze River Ecological Environmental Protection Group Co., Ltd., Mr. Liu Guofeng, director of Alibaba Group (vice president of Training College of Taobao University), made the speech.

Latest news
BirdoTech Successfully Settled in Lingang Area of the Shanghai Pilot
BirdoTech 3rd. R&D Center in Chongqing International Biological City
2020 CPhI Closing: BirdoTech's first appearance